Sleep Number Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 0/6
Sleep Number hat ein Gesamteigenkapital von $-578.5M und eine Gesamtverschuldung von $588.2M, wodurch sich der Verschuldungsgrad auf -101.7% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen $680.1M bzw. $1.3B. Sleep Number Das EBIT des Unternehmens beträgt $4.1M, so dass der Zinsdeckungsgrad 0.1 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von $1.7M.
Wichtige Informationen
-101.68%
Verhältnis von Schulden zu Eigenkapital
US$588.20m
Verschuldung
| Zinsdeckungsgrad | 0.08x |
| Bargeld | US$1.69m |
| Eigenkapital | -US$578.47m |
| Gesamtverbindlichkeiten | US$1.26b |
| Gesamtvermögen | US$680.06m |
Jüngste Berichte zur Finanzlage
Recent updates
SNBR: Marketing Reset And Product Overhaul Will Support Future Earnings Power
Analysts have sharply reduced Sleep Number's blended price target, with recent resets to $4 and $5 reflecting more cautious views on how current marketing efforts and new product launches are feeding through to sales and earnings. Analyst Commentary Recent Street research on Sleep Number has centered on how well the current marketing push and new product launches might translate into sustained earnings power, with price targets reset into the mid single digits as analysts reassess risk and execution.SNBR: Marketing Reset And Product Overhaul Will Support Future Upside
Narrative Update on Sleep Number The analyst price target on Sleep Number has shifted lower into a $4 to $5 range, as analysts point to limited sales traction so far despite progress on marketing spend and new product launches. Analyst Commentary Recent research points to a mixed view on Sleep Number, with price targets now clustered in the low single digits and ratings held at Neutral.SNBR: Marketing Reset And New Mattress Portfolio Will Support Future Upside
Sleep Number's updated fair value estimate has shifted from $11.00 to $4.50. This reflects analysts' recent cuts to price targets to around $4 to $5 as they weigh ongoing Neutral ratings against limited sales traction, despite some progress in marketing and new product launches.SNBR: Improved Execution And Product Mix Will Support Rich Future P/E
Analysts have modestly increased their price targets on Sleep Number, with recent Street research indicating upward adjustments such as $4 and $7 moves as they factor in updated views on the company. Analyst Commentary Recent research updates point to a more constructive stance on Sleep Number, with price targets adjusted higher as analysts revisit their assumptions around the business and its execution risks.SNBR: Higher Fair Value And Execution Progress Will Support Rich P/E
Narrative Update on Sleep Number The updated analyst price target for Sleep Number moves from $9.00 to $11.00. This reflects analysts’ refreshed views on fair value, discount rate, revenue growth, profit margin, and future P/E following recent target increases from multiple firms.SNBR: Margin Optimism And High Future P/E Will Likely Disappoint
Analysts have raised their price targets on Sleep Number by about $7, citing updated expectations for revenue growth, profit margins and future P/E assumptions that refine their overall outlook on the shares. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the revised price target, which is $7 higher, reflects more confidence in Sleep Number’s ability to translate its current revenue outlook into steadier earnings over time.
Premium Pricing And Flat Revenue Will Pressure Margins And Undermine Turnaround Hopes
Catalysts About Sleep Number Sleep Number designs, manufactures and sells premium adjustable mattresses and sleep systems that focus on comfort, firmness control and temperature management. What are the underlying business or industry changes driving this perspective?SNBR: Elevated Future P/E Will Likely Fail To Support Price
Analysts have raised their fair value estimate for Sleep Number from $5.50 to $9.00, reflecting revisions to revenue growth and profit margin assumptions, as well as a significantly higher future P/E multiple that supports the updated price targets cited in recent research. Analyst Commentary Recent research commentary around Sleep Number centers on how changes to revenue and margin assumptions flow through to the updated fair value and price targets, including the move from a prior US$5.50 view to US$9.00.Sleep Number Corporation's (NASDAQ:SNBR) Shares Climb 38% But Its Business Is Yet to Catch Up
Jan 17
SNBR: Future Earnings Guidance And Margins Will Likely Fail To Support Price
Analysts have modestly adjusted their price targets on Sleep Number, citing refined assumptions around long term revenue growth of 77.30%, a profit margin of 4.86% and a future P/E of 2.62x as key drivers of their updated valuation work. What's in the News Amy O’Keefe has been appointed as Sleep Number’s next Chief Financial Officer, effective December 8, 2025, with interim CFO Bob Ryder staying through December 12, 2025 to support the transition (company announcement).Is There An Opportunity With Sleep Number Corporation's (NASDAQ:SNBR) 48% Undervaluation?
Jan 07SNBR: Future Margin Gains Will Likely Prove Insufficient For Current Price
Narrative Update on Sleep Number Analysts have modestly lowered their price target on Sleep Number to approximately $5.50 per share, reflecting slightly more cautious expectations around the company’s profitability and valuation multiple, while growth assumptions remain largely unchanged. What's in the News Appointed Amy O’Keefe as next Chief Financial Officer, effective December 8, 2025, with interim CFO Bob Ryder supporting a brief transition period through December 12, 2025 (company filing) Highlighted O’Keefe’s more than 30 years of experience driving operational, strategic, and financial transformations across consumer products, technology, and wellness companies, including senior roles at Avaya, Weight Watchers, and Drive DeVilbiss Healthcare (company filing) Reaffirmed 2025 earnings guidance, projecting approximately $1.4 billion in net sales and about 60% gross margin for the full year (company guidance) Revised 2025 outlook earlier in the year to call for roughly $1.4 billion in net sales, indicating stable but not accelerating expectations for revenue growth (company guidance) Reported no share repurchases between June 29 and September 27, 2025, while confirming cumulative buybacks of about 50.1 million shares for $1.77 billion under a long running repurchase program launched in 2006 (company disclosure) Valuation Changes Fair Value Estimate: unchanged at approximately $5.50 per share, indicating no material shift in the intrinsic value assessment.Sleep Number Navigates A Challenging Consumer Market When Time Is Critical
Dec 11SNBR: Modest Margin Improvement Will Likely Fail To Support Current Share Price
Analysts have modestly lowered their price target on Sleep Number to reflect a slightly reduced future earnings multiple of about 2.62 times, while still acknowledging stable fair value at 5.50 dollars, unchanged discount rates, and a marginally improved profit margin outlook. What's in the News Sleep Number appointed Amy O’Keefe as its next Chief Financial Officer, effective December 8, 2025, with interim CFO Bob Ryder supporting the transition through December 12, 2025 (Key Developments) O’Keefe brings more than 30 years of experience in financial and operational transformations across consumer products, technology, and wellness companies, including senior finance roles at Avaya, Weight Watchers, Drive DeVilbiss Healthcare, Savant Systems, and D&M Holdings (Key Developments) The company reaffirmed its full year 2025 guidance, targeting approximately 1.4 billion dollars in net sales and a gross margin of about 60% (Key Developments) Earlier in 2025, Sleep Number revised guidance to project full year net sales of approximately 1.4 billion dollars, signaling a consistent outlook for top line performance (Key Developments) Under its long running share repurchase program launched in 2006, the company reported no share buybacks between June 29 and September 27, 2025, while confirming cumulative repurchases of 50,132,467 shares for 1.77 billion dollars (Key Developments) Valuation Changes Fair Value: Unchanged at 5.50 dollars per share, indicating no revision to the intrinsic value estimate.SNBR: Margin Gains Will Strengthen Bullish Outlook Despite Slower Top Line
Analysts have lowered their price target for Sleep Number from $6.95 to $2.69, citing reduced revenue growth expectations. However, they also note improved profit margin projections.SNBR: Improved Margins And Revenue Will Drive Bullish Sentiment Ahead
Analysts have lowered their price target for Sleep Number from $7.50 to $5.50, reflecting cautious optimism over improved revenue growth and slightly better profit margins, even as valuation multiples decline. What's in the News Sleep Number Corporation revised its earnings guidance for 2025.Optimistic Investors Push Sleep Number Corporation (NASDAQ:SNBR) Shares Up 34% But Growth Is Lacking
Jul 29Sleep Number Corporation's (NASDAQ:SNBR) 62% Price Boost Is Out Of Tune With Revenues
May 09Analysts Have Been Trimming Their Sleep Number Corporation (NASDAQ:SNBR) Price Target After Its Latest Report
May 03
Cost Cuts And Product Differentiation Will Improve Operations
Product innovation in Climate Series beds and ARU expansion highlights potential revenue growth through consumer-focused differentiation.Sleep Number Crashes As Risks Are Mounting, But Not Everything Is Lost
Mar 12Sleep Number Corporation's (NASDAQ:SNBR) 29% Price Boost Is Out Of Tune With Revenues
Dec 04Sleep Number: Navigating Market Cycles While Building Operational Excellence
Nov 26Sleep Number Corporation (NASDAQ:SNBR) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year
Nov 02Revenues Not Telling The Story For Sleep Number Corporation (NASDAQ:SNBR) After Shares Rise 29%
Oct 05Sleep Number- Coping Well In A Difficult Environment
Sep 17Optimistic Investors Push Sleep Number Corporation (NASDAQ:SNBR) Shares Up 28% But Growth Is Lacking
Aug 18Some Sleep Number Corporation (NASDAQ:SNBR) Shareholders Look For Exit As Shares Take 28% Pounding
Jun 19Sleep Number: Re-Rating Following Decline In Performance
Mar 29Is It Too Late To Consider Buying Sleep Number Corporation (NASDAQ:SNBR)?
Dec 11Bearish: Analysts Just Cut Their Sleep Number Corporation (NASDAQ:SNBR) Revenue and EPS estimates
Nov 09Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: SNBR ein negatives Eigenkapital aufweist, was eine ernstere Situation darstellt als kurzfristige Vermögenswerte, die die kurzfristigen Verbindlichkeiten nicht decken.
Langfristige Verbindlichkeiten: SNBR ein negatives Eigenkapital aufweist, was eine ernstere Situation darstellt als kurzfristige Vermögenswerte, die die langfristigen Verbindlichkeiten nicht decken.
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: SNBR ein negatives Eigenkapital aufweist, was eine ernstere Situation darstellt als ein hoher Schuldenstand.
Schulden abbauen: SNBRDas Unternehmen hat ein negatives Eigenkapital, so dass wir nicht prüfen müssen, ob sich die Schulden im Laufe der Zeit verringert haben.
Schuldendeckung: SNBRDer operative Cashflow des Unternehmens ist negativ, so dass die Schulden nicht ausreichend gedeckt sind.
Zinsdeckung: SNBRDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (0.1x Deckung) nicht gut gedeckt.
Bilanz
Entdecken Sie finanziell stabile Unternehmen
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/05 01:30 |
| Aktienkurs zum Tagesende | 2026/05/05 00:00 |
| Gewinne | 2026/01/03 |
| Jährliche Einnahmen | 2026/01/03 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Sleep Number Corporation wird von 15 Analysten beobachtet. 4 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| null null | Argus Research Company |
| Jessica Schoen Mace | Barclays |
| Curtis Nagle | BofA Global Research |